Founded in Israel, Stemrad is dedicated to developing personal protective equipment designed to shield individuals from the harmful effects of acute radiation syndrome and sickness. The company's core mission is to enhance safety for those exposed to high doses of radiation, particularly focusing on protecting the bone marrow, which is crucial for blood production. Stemrad's innovative solutions cater to various markets, including medical, military, and nuclear industries, ensuring comprehensive radiation protection.
Stemrad has garnered attention from notable figures and investors in the tech and healthcare sectors. The company has achieved significant milestones, including the development of its flagship product, the 360 Gamma, which has been adopted by various emergency response teams and military units globally. Stemrad's impact is profound, providing life-saving protection to professionals in high-risk environments and contributing to advancements in radiation safety technology.
